Literature DB >> 9849574

The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia.

K Yoshinaga1, H Sasano, T Furukawa, H Yamakawa, M Yuki, S Sato, A Yajima, A Horii.   

Abstract

To pursue the pathogenesis of endometrial carcinogenesis, we investigated microsatellite instability, mutations in the PTEN, TGF beta RII, IGFIIR, and BAX genes, and LOHs on 10q in 18 putative endometrial premalignant lesions (11 endometrial atypical hyperplasias (ATHs), 2 complex hyperplasias, and 5 simple hyperplasias) as well as 8 endometrial cancers (ECs). In the ATH cases, MSIs as well as LOHs at 10q were observed at frequencies similar to those in ECs. Mutations in PTEN, BAX, and IGFIIR were observed only in ATHs and ECs. These results suggest that (1) PTEN, BAX, and IGFIIR are already mutated in ATHs, and (2) ATH is one of the precursor lesions which could lead to EC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849574      PMCID: PMC5921707          DOI: 10.1111/j.1349-7006.1998.tb00485.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


atypical hyperplasia BCL2‐associated X protein complex hyperplasia endometrial carcinoma endometrial hyperplasia insulin‐like growth factor II receptor loss of heterozygosity microsatellite instability polymerase chain reaction phosphatase and tensin homolog deleted on chromosome ten simple hyperplasia transforming growth factor β receptor type II
  19 in total

1.  The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group.

Authors:  N Terakawa; J Kigawa; Y Taketani; H Yoshikawa; A Yajima; K Noda; H Okada; J Kato; M Yakushiji; O Tanizawa; S Fujimoto; S Nozawa; T Takahashi; K Hasumi; N Furuhashi; T Aono; A Sakamoto; M Furusato
Journal:  J Obstet Gynaecol Res       Date:  1997-06       Impact factor: 1.730

2.  PTEN1 is frequently mutated in primary endometrial carcinomas.

Authors:  D Kong; A Suzuki; T T Zou; A Sakurada; L W Kemp; S Wakatsuki; T Yokoyama; H Yamakawa; T Furukawa; M Sato; N Ohuchi; S Sato; J Yin; S Wang; J M Abraham; R F Souza; K N Smolinski; S J Meltzer; A Horii
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

3.  Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer.

Authors:  S Nagase; H Yamakawa; S Sato; A Yajima; A Horii
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

4.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

5.  Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

Authors:  H Tashiro; M S Blazes; R Wu; K R Cho; S Bose; S I Wang; J Li; R Parsons; L H Ellenson
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.

Authors:  P Cairns; K Okami; S Halachmi; N Halachmi; M Esteller; J G Herman; J Jen; W B Isaacs; G S Bova; D Sidransky
Journal:  Cancer Res       Date:  1997-11-15       Impact factor: 12.701

7.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

8.  PTEN/MMAC1 mutations in endometrial cancers.

Authors:  J I Risinger; A K Hayes; A Berchuck; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

9.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

10.  Deletion mapping on chromosome 10q25-q26 in human endometrial cancer.

Authors:  S Nagase; S Sato; F Tezuka; Y Wada; A Yajima; A Horii
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more
  5 in total

1.  Diagnosis of premalignant endometrial disease.

Authors:  G L Mutter
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma.

Authors:  R Nakashima; H Song; T Enomoto; Y Murata; M R McClaid; B C Casto; C M Weghorst
Journal:  Gene Expr       Date:  1999

Review 3.  Precursors of endometrial and ovarian carcinoma.

Authors:  Robert J Kurman; Thomas G McConnell
Journal:  Virchows Arch       Date:  2009-10-27       Impact factor: 4.064

4.  beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.

Authors:  M Saegusa; M Hashimura; T Yoshida; I Okayasu
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

5.  Expression of the DMBT1 gene is frequently suppressed in human lung cancer.

Authors:  H Takeshita; M Sato; H O Shiwaku; S Semba; A Sakurada; M Hoshi; Y Hayashi; Y Tagawa; H Ayabe; A Horii
Journal:  Jpn J Cancer Res       Date:  1999-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.